News

News

FOXTROT™ PRO Gains Market Approval in Indonesia -

...

MicroPort® Orthopedics Donates Hip Prosthesis in a Charitable SuperPath™ Surgery -

...

Tubridge™ Granted Green Channel Status for CFDA Approval -

...

MicroPort® Awarded Five Star Credit Enterprise -

...

MicroPort® EP Attends the 8th Atrial Fibrillation Key Technology International Forum -

...

MicroPort® Attends AsiaPCR 2016 -

...

MicroPort® Firesorb Bioresorbable Rapamycin Target Eluting Coronary Scaffold System Completes First Successful Implantation in the First FIM Clinical Trial -

...

Dongguan Kewei Disposable Arterial Micro Plug Filter Obtains EU CE Certification -

...

Disposable Intravascular Catheter Accessories Product Obtains CFDA Certification -

...

MicroPort® Science and Technology Innovation Platform Won the State Science and Technology Progress Award -

...

MicroPort® D-Pulse Product Obtained CFDA Registration Certificate -

...

MicroPort® EP OptimAblate™ Cardiac RF Generator and OptimAblate™ Irrigation Pump Obtained CE Certification of EU -

...

Product of MicroPort® EP Completed First Clinical Case Observation -

...

Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved -

...

MicroPort® Completed the First Distant Interactive Surgery in the Field of Coronary Interventional Treatment -

...

First Patient Enrolled in MicroPort's TARGET All Comer Clinical Trial, a Multi-center, Prospective, Randomized, Controlled, European Clinical Study for the Firehawk Rapamycin Target Eluting Coronary Stent System -

...